# Mechanisms of Ultrasound Neuromodulation Effects in Diabetes

> **NCT06042517** · NA · RECRUITING · sponsor: **Yale University** · enrollment: 77 (estimated)

## Conditions studied

- Insulin Sensitivity

## Interventions

- **DEVICE:** Ultrasound
- **DIAGNOSTIC_TEST:** OGTT with unlabeled glucose and liver NMR
- **DIAGNOSTIC_TEST:** OGTT with carbon-13 labeled glucose and liver NMR
- **DIAGNOSTIC_TEST:** CGM glucose reading
- **DIAGNOSTIC_TEST:** HEC - Hyperinsulinemic-Euglycemic-Clamp

## Key facts

- **NCT ID:** NCT06042517
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-09-30
- **Primary completion:** 2027-09-30
- **Final completion:** 2027-09-30
- **Target enrollment:** 77 (ESTIMATED)
- **Last updated:** 2025-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06042517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06042517, "Mechanisms of Ultrasound Neuromodulation Effects in Diabetes". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT06042517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*